Announcing the Winners of our Science Image Contest

 Dear Rosetta Community,


We are thrilled to announce the winners of our recent Science Image Contest! The response we received was great, with an array of breathtaking images showcasing the beauty and complexity of our communities' scientific research. After much deliberation, we have selected the top three submissions that stood out for their creativity and visual impact.


Without further ado, let's congratulate our winners:


1st Place: Tom Schlegel - $500

Tom's image captivated us with its stunning detail and artistic composition. Congratulations, Tom, on your well-deserved first-place win!


Colorful blender rendering of the lumazine synthase from the hyperthermophile Aquifex aeolicus.


2nd Place: Ian Haydon - $300

Ian's submission impressed us with its striking visuals and unique perspective. His image effortlessly combines artistry with science. Congratulations, Ian, on securing second place!


Analogous to perfectly straight, twist-free pieces of lumber, this new class of de novo designed proteins can be attached together or made longer to create a wide range of intricate nanoscale objects.


3rd Place: Jorge Gonzalez - $200

Jorge's image caught our attention with its mesmerising beauty and thought-provoking content. Congratulations, Jorge, on achieving third place!

In the loom of evolution, positive design interweaves stability, while negative design unravels the trappings of the woven and unraveled landscape, like silk threads in a metamorphosis, following the principle of minimal frustration of protein folding.


We will be reaching out to the winners shortly to arrange prize distribution. By participating in the contest, all entrants have agreed to share the copyright with the Rosetta Commons, allowing us to feature their images on our website and related communications. We would like to extend our heartfelt thanks to everyone who participated in the contest.


Best regards,

The Rosetta Commons Website Team

Comments

Post a Comment

Popular posts from this blog

Introducing Rosetta Commons Foundation and Levitate Bio

Dear members of the Rosetta Community, The Rosetta Commons Board is excited to announce a significant milestone in the evolution of our community and a step on our path toward the Future of Rosetta. We have created a non-profit organization, the Rosetta Commons Foundation, which has established a wholly-owned subsidiary company called Levitate Bio. Levitate Bio provides cloud-based automated protein modeling and design protocols using AI & Rosetta, available through annual subscriptions. With a mission similar to the Rosetta Commons, the Rosetta Commons Foundation aims to foster a collaborative community that contributes to knowledge and tools for computational modeling and design of biological macromolecules. Appointed by the Rosetta Commons Board, the Foundation’s initial Board currently consists of Jeff Gray, Julia Koehler Leman, and David Nannemann. We expect this leadership structure to evolve soon, with a more permanent Board structure announced in due course. What is unique...
Read more

Announcing the winners of the Winter Protein Design Games 2024: Unleashing Innovation in Enzyme Engineering

Image
The Winter RosettaCon organizers want to thank Liberum Bio for sponsoring the experimental validation of the designs that they carried out in 8 days starting from digital sequences! Liberum Bio produces proteins at high yields in cell-free systems at a fraction of the usual cost and time via highly engineered strains and state-of-the art reaction mixtures. At Winter RosettaCon 2024 in Boston, the Rosetta Commons in partnership with Liberum Biotech hosted the inaugural Winter Protein Design Games , focusing on the design of Tobacco Etch Virus (TEV) protease variants. TEV protease is commonly used as a tool for sequence-specific protein cleavage, facilitating the purification of proteins without affinity tags. The competition challenged cross-institutional participating teams to engineer TEV proteases that exhibited enhanced substrate cleavage efficiency over the wild-type enzyme.  The competition was straightforward: design TEV protease variants that outperform the wild type in cl...
Read more

Announcing Rosetta's Transition to a Public Repository (including Licensing Changes)

Dear Rosetta Community and users of Rosetta, We're excited to announce that we have moved the Rosetta code repository to a public repository! We have made this move to honor our longstanding philosophy of sharing our work publicly and making it broadly accessible to scientists. This change marks a new chapter for Rosetta, where future developments will be more collaborative and accessible.  This move required crucial changes to our workflow and licensing terms that are designed to streamline contributions to our platform. The new repository is accessible at https://github.com/RosettaCommons/rosetta . Licensing adjustments: The repository's public status means that non-commercial users no longer need to explicitly sign up for a license to access Rosetta. However, despite being publicly accessible, Rosetta is not open source; redistribution restrictions and other licensing restrictions remain in place for all users. For our commercial users, the existing license will continue as...
Read more